Enzyl 40 mg Capsule

Enzyl 40 mg Capsule contains enzalutamide 40 mg, an androgen receptor inhibitor used as an anticancer medicine. It is primarily used in the treatment of advanced prostate cancer in specific clinical settings. The capsule is taken orally according to the treatment plan prescribed by an oncologist.

BUY NOW

Enzalutamide works by blocking androgen receptor signaling, which can help inhibit hormone-driven growth of prostate cancer cells. Enzyl 40 mg is manufactured by Sun Pharmaceutical Industries Ltd and is listed as a pack of 28 capsules. The capsule is intended for oral use and should be taken consistently as directed by the treating physician. Treatment dosage and duration depend on the patient’s condition and the prescribed oncology regimen.

Technical Specification

Specification Details
Active Ingredient Enzalutamide
Strength 40 mg
Dosage Form Capsule
Therapeutic Class Androgen Receptor Inhibitor
Route of Administration Oral
Pack Size 28 capsules

Product Also Known As

Enzyl 40 mg Capsule, Enzyl 40mg Capsule, Enzalutamide 40 mg Capsule, Enzalutamide 40mg Capsule, Enzalutamide Anticancer Capsule, Enzalutamide Prostate Cancer Capsule, Androgen Receptor Inhibitor Capsule